MIRABEGRON

Product NDC
68180-151
11-digit product format
681800151
Labeler code
68180
Product ID
68180-151_b26f08e4-dfe4-4a0f-b6b5-e9abb495e415
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
mirabegron
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Lupin Pharmaceuticals, Inc.
Application
ANDA209485
Marketing category
ANDA
Marketing start
2024-04-19
Substance
MIRABEGRON
Active strength
25 mg/1
Pharmacologic classes
Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
MVR3JL3B2VMIRABEGRON223673-61-8MIRABEGRON

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
68180-151-066818001510630 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-151-06) 2024-04-19NoNoHistorical
68180-151-096818001510990 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68180-151-09) 2024-04-19NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
MIRABEGRONLupin Pharmaceuticals, Inc. | LUPIN LIMITED2025-12-24HUMAN PRESCRIPTION DRUG LABEL19
MIRABEGRONBryant Ranch Prepack2025-09-26HUMAN PRESCRIPTION DRUG LABEL100
MIRABEGRONBryant Ranch Prepack2025-09-26HUMAN PRESCRIPTION DRUG LABEL100